U.S. markets closed

FDCTech, Inc. (FDCT)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1000-0.0049 (-4.67%)
At close: 3:48PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1049
BidN/A x N/A
AskN/A x N/A
Day's Range0.0946 - 0.1049
52 Week Range0.0900 - 0.9450
Avg. Volume58,659
Market Cap8.735M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0100
Earnings DateNov 03, 2021 - Nov 08, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for FDCT

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    Analyst Report: Pfizer Inc.Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion. Pfizer also spends a leading amount on research and development, close to $8 billion annually. While Pfizer historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.
    Fair Value
    Economic Moat
    5 days agoMorningstar
View more
  • GlobeNewswire

    FDCTech Announces the Termination of Genesis Financial Inc. Stock Purchase Agreement

    Irvine, CA, Aug. 27, 2021 (GLOBE NEWSWIRE) -- FDCTech, Inc. ("FDC" or the "Company," OTCQB: FDCT), a fully integrated financial technology company with a full suite of digital financial services solutions, today announced that it had terminated effective immediately the Stock Purchase Agreement (the "Agreement"), dated June 2, 2021, with the Shareholders of Genesis Financial, Inc., a Wyoming corporation ("Genesis" or "Seller"). The Company could not complete nor qualify the Agreement as Genesis

  • GlobeNewswire

    FDCTech Launches Condor Price Hub, A New Connectivity As a Service Platform to Enhance Market Trading Liquidity And Execution

    Irvine, CA, Aug. 17, 2021 (GLOBE NEWSWIRE) -- FDCTech, Inc. ("FDC" or the "Company," OTCQB: FDCT), a fully integrated financial technology company with a full suite of digital financial services solutions, today announced the launch of Condor Price Hub, new connectivity as a service platform that enhances market trading liquidity and execution. This platform offers retail forex brokers, hedge funds, and emerging market banks ('takers') the opportunity to connect to institutional multi-asset mark

  • GlobeNewswire

    FDCTech appoints Charles R. Provini as the new independent Director

    Charles Provini has stellar leadership and governance experience spanning several decades, starting from United States Naval Academy to the private sector. He brings deep insights into asset management, investment banking, advisory services, and technology. He is a frequent speaker at financial seminars and has appeared on several mainstream media outlets discussing financial markets and, more recently, the solar industry. Irvine, CA, July 08, 2021 (GLOBE NEWSWIRE) -- FDCTech, Inc. ("FDC" or the